Who decides the cost of medicines in India?
India’s separation of medicine licensing under CDSCO and pricing under NPPA presents a policy challenge. Stronger coordination,supported by pharmaceutical, clinical and health-economic expertise, could bridge this gap
Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].

